Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Equity: 2021-2025

Historic Return on Equity for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to -0.30%.

  • Arcutis Biotherapeutics' Return on Equity rose 84.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year increase of 84.00%. This contributed to the annual value of -1.14% for FY2024, which is 62.00% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Return on Equity stood at -0.30% for Q3 2025, which was up 54.94% from -0.66% recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Return on Equity ranged from a high of -0.30% in Q3 2025 and a low of -4.21% during Q3 2023.
  • For the 3-year period, Arcutis Biotherapeutics' Return on Equity averaged around -1.74%, with its median value being -1.14% (2024).
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by 288bps in 2023, then spiked by 307bps in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Return on Equity (Quarterly) stood at -0.63% in 2021, then crashed by 67bps to -1.30% in 2022, then crashed by 257bps to -3.87% in 2023, then soared by 298bps to -0.89% in 2024, then surged by 84bps to -0.30% in 2025.
  • Its Return on Equity was -0.30% in Q3 2025, compared to -0.66% in Q2 2025 and -0.86% in Q1 2025.